Jc. Copin et al., ALMITRINE PREVENTS SOME HYPOXIA-INDUCED METABOLIC INJURY IN RAT ASTROCYTES, Molecular and chemical neuropathology, 20(2), 1993, pp. 97-109
During reperfusion of ischemic brain tissue, the production of reactiv
e oxygen species initiates several modifications of the astroglial fun
ctional and ultrastructural integrity. During 24 h after ischemic trea
tment, modification of cellular superoxide free radical scavenging sys
tems have been observed in primary culture of rat astroglial cell. Mit
ochondrial Mn superoxide dismutase activity (Mn-SOD) gradually decreas
es, whereas that of the cytosolic Cu,Zn form of the enzyme remains una
ffected. We observed in parallel a significant decrease of glutamine s
ynthetase (GS), an astrocyte specifically located enzyme. Addition of
almitrine (dialylamine-4',6'-triazinyl 2')-1-(bis-parafluorobenzydryl)
-4-piperazine or dibucaine (a phospholipase A2 inhibitor) antagonizes
the decrease of Mn-SOD activity, but does not affect modification of G
S activity. Combined effects are observed by simultaneous addition of
both drugs. Our data demonstrate that almitrine may increase the synth
esis of some mitochondrial proteins, like Mn-SOD, and provide support
for further study on the therapeutic potential of almitrine in ischemi
c astroglial cell injury.